Virta Health

About Virta Health

Virta Health was founded in 2014 with a mission that remains unique in digital health: reversing type 2 diabetes through nutritional intervention, specifically a physician-supervised ketogenic diet. The company has published peer-reviewed research demonstrating that its approach can reduce or eliminate the need for diabetes medications in a significant percentage of patients. When GLP-1 medications emerged as powerful tools for metabolic health, Virta integrated them into its existing clinical framework — not as a replacement for its nutrition-first philosophy, but as a complementary tool for patients who need pharmacological support alongside dietary change.

Like Omada, Virta primarily delivers its program through employer and health plan partnerships, meaning most patients access the platform at no direct cost. The program includes a dedicated physician or nurse practitioner, a registered dietitian, comprehensive lab testing (including metabolic panels and A1C monitoring), and continuous remote monitoring through connected devices. GLP-1 medications are prescribed when clinically appropriate, but they are always framed within Virta’s broader metabolic health protocol. This integrated approach is designed to produce sustainable results even if medication is eventually discontinued.

Virta’s clinical support level is among the highest in the telehealth weight loss space. Patients have direct messaging access to their care team, regular check-ins, and a structured nutrition curriculum that evolves as metabolic markers improve. The program tracks biomarkers over time, adjusting both dietary recommendations and medication as needed. For patients with type 2 diabetes or prediabetes, this level of metabolic management goes far beyond what a standard GLP-1 prescription service offers. Virta’s published outcomes include an average A1C reduction of 1.3% and significant reductions in diabetes medication use at one year.

One important consideration is Virta’s C- rating with the Better Business Bureau, which is notably lower than its clinical reputation might suggest. BBB ratings reflect complaint resolution processes and business responsiveness, not clinical quality, and Virta’s lower grade appears tied to customer service friction rather than medical concerns. The company does not have a Trustpilot presence, so independent consumer sentiment data is limited. Our editorial team recommends prospective patients weigh the strong clinical evidence alongside the BBB rating when making their decision.

Virta is not a simple GLP-1 prescription service — it is a comprehensive metabolic health program that may include GLP-1 medications as one component. Patients who want quick, standalone access to semaglutide or tirzepatide without dietary commitments will find Virta’s model more intensive than they need. But for patients with metabolic conditions who want a physician-led, nutrition-integrated approach with rigorous lab monitoring, Virta offers a depth of care that few telehealth platforms can match.

Virta Health GLP-1 Medications

At a Glance